Council to Advance Human Health (CAHH)

Read about Convelo in The Daily: 

• Case Western Reserve ‘spinout’ company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders

• Medicine’s Drew Adams and Paul Tesar publicly launch Convelo Therapeutics

Read about Haima in the press: 

• New CWRU, Haima Therapeutics' blood-clotting platelet simulators could save lives (video)

• Case Western Reserve and Haima Therapeutics sign option license to develop SynthoPlate

• Haima Therapeutics, a CWRU spinoff, funded by Department of Defense

• Scientists work to freeze-dry synthetic platelets

Read about Luminary in The Daily: 

• Luminary Therapeutics and Case Western Reserve University enter formal collaboration for development of BAFF CAR

Read about Mosaic in the press: 

• Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases

• A Common Plant Virus Is an Unlikely Ally in the War on Cancer

• Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases

Read about NervGen in The Daily:

• Case Western Reserve, NervGen sign license agreement to develop therapies for spinal-cord injury and other nerve-damage conditions

• Case Western Reserve University startup, NervGen Pharma, raises $7.5M from initial public offering

Read more about Rodeo in the press: 

• Case Western Reserve University researchers develop therapeutic to enhance tissue repair and regeneration

• Putting precision care on the spot

• Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read about Q2 in The Daily: 

• Case Western Reserve embarks on innovative path to treat infections of drug-resistant superbugs such as MRSA without antibiotics

• Case Western Reserve researchers cure drug-resistant infections without antibiotics

• $1M, two-year grant from Dr. Ralph and Marian Falk Medical Research Trust to advance CWRU research on therapies for Huntington’s disease

Read about Tevard in The Daily:

• Luminary Therapeutics and Case Western Reserve University enter formal collaboration for development of BAFF CAR